These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 18342224)

  • 1. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.
    Zile MR; Bourge RC; Bennett TD; Stevenson LW; Cho YK; Adamson PB; Aaron MF; Aranda JM; Abraham WT; Smart FW; Kueffer FJ
    J Card Fail; 2008 Dec; 14(10):816-23. PubMed ID: 19041044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial.
    Adamson PB; Gold MR; Bennett T; Bourge RC; Stevenson LW; Trupp R; Stromberg K; Wilkoff BL; Costanzo MR; Luby A; Aranda JM; Heywood JT; Baldwin HA; Aaron M; Smith A; Zile M
    Congest Heart Fail; 2011; 17(5):248-54. PubMed ID: 21906250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in heart failure patients.
    Teerlink JR
    J Am Coll Cardiol; 2008 Mar; 51(11):1080-2. PubMed ID: 18342225
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable hemodynamic monitoring (the Chronicle IHM system): remote telemonitoring for patients with heart failure.
    Ho C
    Issues Emerg Health Technol; 2008 Jan; (111):1-4. PubMed ID: 18354860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial.
    Goldberg LR; Piette JD; Walsh MN; Frank TA; Jaski BE; Smith AL; Rodriguez R; Mancini DM; Hopton LA; Orav EJ; Loh E;
    Am Heart J; 2003 Oct; 146(4):705-12. PubMed ID: 14564327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic ambulatory intracardiac pressures and future heart failure events.
    Stevenson LW; Zile M; Bennett TD; Kueffer FJ; Jessup ML; Adamson P; Abraham WT; Manda V; Bourge RC
    Circ Heart Fail; 2010 Sep; 3(5):580-7. PubMed ID: 20562255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure.
    Steinhaus D; Reynolds DW; Gadler F; Kay GN; Hess MF; Bennett T;
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):747-53. PubMed ID: 16104999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST.
    Shah MR; Stinnett SS; McNulty SE; Gheorghiade M; Zannad F; Uretsky B; Adams KF; Califf RM; O'connor CM
    Am Heart J; 2001 Jun; 141(6):908-14. PubMed ID: 11376303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A wireless pressure sensor for monitoring pulmonary artery pressure in advanced heart failure: initial experience.
    Castro PF; Concepción R; Bourge RC; Martínez A; Alcaino M; Deck C; Ferrada M; Alfaro M; Perrone S
    J Heart Lung Transplant; 2007 Jan; 26(1):85-8. PubMed ID: 17234522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial.
    Kimmelstiel C; Levine D; Perry K; Patel AR; Sadaniantz A; Gorham N; Cunnie M; Duggan L; Cotter L; Shea-Albright P; Poppas A; LaBresh K; Forman D; Brill D; Rand W; Gregory D; Udelson JE; Lorell B; Konstam V; Furlong K; Konstam MA
    Circulation; 2004 Sep; 110(11):1450-5. PubMed ID: 15313938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
    Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
    Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial.
    Sharma GV; Woods PA; Lindsey N; O'Connell C; Connolly L; Joseph J; McIntyre KM
    J Card Fail; 2011 Sep; 17(9):718-25. PubMed ID: 21872140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR; Conraads V; Tavazzi L; Yu CM;
    J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.